Insulin secretion predicts the response to therapy with exenatide plus pioglitazone, but not to basal/bolus insulin in poorly controlled T2DM patients: Results from the Qatar study
Muhammad Abdul‐Ghani; Osama Migahid; Ayman Megahed; Rajvir Singh; Dalia Kamal; Ralph A. DeFronzo; Amin Jayyousi
Author Information: Academic Health System
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.